G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Clinical trial NCT04713956 · UNKNOWN

Trial details

NCT number: NCT04713956
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Allogeneic Hematopoietic Stem Cell Transplantation Conditioning

Start date: 2021-01-15
Primary completion: 2023-07-31
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.